Skip Nav Destination
1-4 of 4
Si Kei Lou, Hyang Mi Ko, Tomonari Kinoshita, Scott MacDonald, Jessica Weiss, Katarzyna Czarnecka-Kujawa, Scott L. Boerner, Kazuhiro Yasufuku, Ming-Sound Tsao, Joerg Schwock
Acta Cytologica (2020) 64 (6): 577–587.
Published Online: 29 June 2020
...Si Kei Lou; Hyang Mi Ko; Tomonari Kinoshita; Scott MacDonald; Jessica Weiss; Katarzyna Czarnecka-Kujawa; Scott L. Boerner; Kazuhiro Yasufuku; Ming-Sound Tsao; Joerg Schwock Background: Programmed death ligand-1 (PD-L1) assessed by immunohistochemistry (IHC) is used as biomarker for pembrolizumab...
Acta Cytologica (2020) 64 (1-2): 103–123.
Published Online: 10 April 2019
.... Pancreatic cancer Molecular testing Genetic alteration Biomarker Therapeutic target The advent of next-generation nucleic acid sequencing techniques, combined with increased interest, has allowed for extensive genetic and epigenetic characterization in recent years of pancreatic neoplasia...
Joana Fernandes Marques, Joana Pereira Reis, Gabriela Fernandes, Venceslau Hespanhol, José Carlos Machado, José Luís Costa
Acta Cytologica (2019) 63 (6): 456–465.
Published Online: 08 March 2019
... Disease monitoring Biomarker Sequencing The discovery of circulating nucleic acids, namely circulating free DNA (cfDNA), in peripheral blood dates back to the late 1940s when Mandel and Métais [ 1 ] first identified DNA in circulation in peripheral blood of healthy individuals, pregnant women...
Acta Cytologica (2017) 61 (3): 230–236.
Published Online: 19 May 2017
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cervical cytology p16 Ki-67 Biomarker Methodical limitations CIN Immunochemical detection of the protein p16 INK4a , the overexpression of which is a surrogate...